This study is designed to evaluate the efficacy of personalized alternating current stimulation in the treatment of emotional disorders in patients with inflammatory demyelination of the central nervous system.
Patients diagnosed with inflammatory demyelinating diseases of the central nervous system, such as neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS)
Hamilton Anxiety Scale (HAM-A) score > 14
Aged between 18 and 65 years, with no gender restrictions
Receiving stable doses of immunosuppressive therapy for at least one month
Recorded relapse within the past month
Recent medication adjustments or treatments involving modified electroconvulsive therapy, transcranial magnetic stimulation, or other neuromodulation techniques within the past month
Participation in any other clinical study within the past month or currently
Presence of cochlear implants, cardiac pacemakers, or implanted stimulators in the brain